Cargando…
Unusual cause of hyperammonemia in two cases with short-term and long-term valproate therapy successfully treated by single dose carglumic acid
Valproic acid (VPA) is an antiepileptic drug which is used in the treatment of various seizure disorders including tonic-clonic, myoclonic, absence, partial seizures and psychiatric disorders. VPA is usually well tolerated, but severe adverse effects may occur. Hyperammonaemic encephalopathy (HE) is...
Autores principales: | Kasapkara, Çiğdem Seher, Kanğın, Murat, Taş, Funda Feryal, Topçu, Yasemin, Demir, Remezan, Özbek, Mehmet Nuri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888049/ https://www.ncbi.nlm.nih.gov/pubmed/24470826 http://dx.doi.org/10.4103/1817-1745.123697 |
Ejemplares similares
-
Use of carglumic acid in valproate‐induced hyperammonemia: 25 pediatric cases
por: Palomino Pérez, Laura María, et al.
Publicado: (2020) -
Secondary Hemophagocytosis in Propionic Acidemia
por: Kasapkara, Cigdem Seher, et al.
Publicado: (2015) -
Two Siblings With Valproate-Related Hyperammonemia and Novel Mutations in Glutamine Synthetase (GLUL) Treated With Carglumic Acid
por: Bennett, Jennifer, et al.
Publicado: (2020) -
Carglumic acid: an additional therapy in the treatment of organic acidurias with hyperammonemia?
por: Levrat, Virginie, et al.
Publicado: (2008) -
New developments in the treatment of hyperammonemia: emerging use of carglumic acid
por: Daniotti, Marta, et al.
Publicado: (2011)